Device Trial Radar · NCT07876115
Cross-Over Study Evaluating the TASKA GEN2 Myoelectric Hand Prosthesis
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Jun 13, 2025
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- TASKA ProstheticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 15, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective multicentre randomized cross-over post-market clinical follow-up study compares the TASKA GEN2 multi-grip myoelectric hand prosthesis with marketed comparator prostheses in adults with upper-limb amputation. The study evaluates specific function using the Patient-Specific Functional Scale together with upper-limb function, comfort, quality of life, satisfaction and safety outcomes.
Conditions
- Upper Limb Amputation
- Transradial Amputation
- Transhumeral Amputation
Interventions
TASKA GEN2 Multi-Grip Myoelectric Hand ProsthesisDevice
Participants use the Taska Gen2 multi-grip myoelectric prosthesis
Michelangelo or I-Limb Ultra multi-grip myoelectric prosthesisDevice
Participants use their usual marketed multi-grip myoelectric hand prosthesis (Michelangelo or I-Limb Ultra) during the relevant 28-day study period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Patient-Specific Functional Scale (PSFS).Time frame: End of each 28-day wearing period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Multiple facilities
Multiple Locations, France · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.